• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中枢神经系统疾病中的巨噬细胞移动抑制因子(MIF):功能调节及潜在治疗应用

Macrophage migration inhibitory factor (MIF) in CNS diseases: Functional regulation and potential therapeutic indication.

作者信息

Zhang Yu, Yu Zhexiang, Ye Na, Zhen Xuechu

机构信息

Jiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, China.

Department of Pharmacy, Hubei Provincial Clinical Research Center for Parkinson's Disease, Xiangyang Key Laboratory of Movement Disorders, Xiangyang No.1 People' Hospital, Hubei University of Medicine, Xiangyang 441000, China.

出版信息

Fundam Res. 2023 May 30;4(6):1375-1388. doi: 10.1016/j.fmre.2023.05.008. eCollection 2024 Nov.

DOI:10.1016/j.fmre.2023.05.008
PMID:39734533
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11670708/
Abstract

Macrophage migration inhibitory factor (MIF) is a multifunctional protein that possesses cytokine, enzyme, and endocrine activities and acts as a chaperone-like molecule. Owing to its immune-inflammatory regulatory properties, the role of MIF has long been an attractive target in research on various autoimmune and inflammatory disorders. MIF is also widely expressed in the central nervous system (CNS), and its potential roles in CNS disorders have become a focus to elucidate the physiological and pathological effects of MIF and to explore its potential significance in the treatment of CNS diseases. Previously, the majority of work on MIF functional regulation was focused on MIF tautomerase inhibitors. However, mounting information has indicated that the functions of MIF extend far beyond its tautomerase activity. Here, we review the recent advances in understanding the complex roles of MIF in the pathogenesis of CNS disorders as well as the discovery and design of small molecules targeted to tautomerase and nuclease of MIF.

摘要

巨噬细胞迁移抑制因子(MIF)是一种多功能蛋白,具有细胞因子、酶和内分泌活性,并作为一种分子伴侣样分子发挥作用。由于其免疫炎症调节特性,长期以来,MIF的作用一直是各种自身免疫性和炎症性疾病研究中一个有吸引力的靶点。MIF在中枢神经系统(CNS)中也广泛表达,其在中枢神经系统疾病中的潜在作用已成为阐明MIF的生理和病理作用以及探索其在中枢神经系统疾病治疗中的潜在意义的研究重点。此前,大多数关于MIF功能调节的研究都集中在MIF互变异构酶抑制剂上。然而,越来越多的信息表明,MIF的功能远远超出其互变异构酶活性。在此,我们综述了在理解MIF在中枢神经系统疾病发病机制中的复杂作用以及针对MIF互变异构酶和核酸酶的小分子的发现与设计方面的最新进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4797/11670708/233ea66f2002/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4797/11670708/88853c5962db/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4797/11670708/de7ef75751ca/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4797/11670708/459b946c1bda/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4797/11670708/4c28239b78e1/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4797/11670708/d00e46ab0de4/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4797/11670708/849624d4546e/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4797/11670708/bf2d4eac5b00/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4797/11670708/233ea66f2002/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4797/11670708/88853c5962db/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4797/11670708/de7ef75751ca/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4797/11670708/459b946c1bda/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4797/11670708/4c28239b78e1/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4797/11670708/d00e46ab0de4/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4797/11670708/849624d4546e/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4797/11670708/bf2d4eac5b00/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4797/11670708/233ea66f2002/gr7.jpg

相似文献

1
Macrophage migration inhibitory factor (MIF) in CNS diseases: Functional regulation and potential therapeutic indication.中枢神经系统疾病中的巨噬细胞移动抑制因子(MIF):功能调节及潜在治疗应用
Fundam Res. 2023 May 30;4(6):1375-1388. doi: 10.1016/j.fmre.2023.05.008. eCollection 2024 Nov.
2
Macrophage migration inhibitory factor and the discovery of tautomerase inhibitors.巨噬细胞移动抑制因子与互变异构酶抑制剂的发现
Curr Pharm Des. 2002;8(14):1297-317. doi: 10.2174/1381612023394674.
3
An integrative in silico methodology for the identification of modulators of macrophage migration inhibitory factor (MIF) tautomerase activity.一种用于鉴定巨噬细胞移动抑制因子 (MIF) 互变异构酶活性调节剂的综合计算方法。
Bioorg Med Chem. 2010 Jul 15;18(14):5425-40. doi: 10.1016/j.bmc.2010.05.010. Epub 2010 May 13.
4
Immune modulation by the macrophage migration inhibitory factor (MIF) family: D-dopachrome tautomerase (DDT) is not (always) a backup system.巨噬细胞移动抑制因子(MIF)家族的免疫调节:D-多巴色素互变异构酶(DDT)并非(总是)备用系统。
Cytokine. 2020 Sep;133:155121. doi: 10.1016/j.cyto.2020.155121. Epub 2020 May 11.
5
Macrophage migration inhibitory factor (MIF) is rendered enzymatically inactive by myeloperoxidase-derived oxidants but retains its immunomodulatory function.巨噬细胞移动抑制因子(MIF)可被髓过氧化物酶衍生的氧化剂酶失活,但保留其免疫调节功能。
Free Radic Biol Med. 2015 Dec;89:498-511. doi: 10.1016/j.freeradbiomed.2015.09.009. Epub 2015 Oct 8.
6
Inhibition of MIF bioactivity by rational design of pharmacological inhibitors of MIF tautomerase activity.通过合理设计巨噬细胞迁移抑制因子(MIF)互变异构酶活性的药理抑制剂来抑制MIF生物活性。
J Med Chem. 2002 Jun 6;45(12):2410-6. doi: 10.1021/jm010534q.
7
A selective small-molecule inhibitor of macrophage migration inhibitory factor-2 (MIF-2), a MIF cytokine superfamily member, inhibits MIF-2 biological activity.一种巨噬细胞移动抑制因子-2(MIF-2)的选择性小分子抑制剂,MIF 细胞因子超家族成员,抑制 MIF-2 的生物学活性。
J Biol Chem. 2019 Dec 6;294(49):18522-18531. doi: 10.1074/jbc.RA119.009860. Epub 2019 Oct 2.
8
Crystal structure of human D-dopachrome tautomerase, a homologue of macrophage migration inhibitory factor, at 1.54 A resolution.人D-多巴色素互变异构酶(巨噬细胞迁移抑制因子的同源物)1.54埃分辨率的晶体结构。
Biochemistry. 1999 Mar 16;38(11):3268-79. doi: 10.1021/bi982184o.
9
Current developments of macrophage migration inhibitory factor (MIF) inhibitors.巨噬细胞移动抑制因子(MIF)抑制剂的最新研究进展。
Drug Discov Today. 2013 Jun;18(11-12):592-600. doi: 10.1016/j.drudis.2012.12.013. Epub 2013 Mar 4.
10
Advances and Insights for Small Molecule Inhibition of Macrophage Migration Inhibitory Factor.小分子抑制巨噬细胞移动抑制因子的研究进展与启示
J Med Chem. 2018 Sep 27;61(18):8104-8119. doi: 10.1021/acs.jmedchem.8b00589. Epub 2018 Jun 4.

引用本文的文献

1
Evaluation of the immunoprotective potential of recombinant EtMIF as a subunit vaccine candidate against infection in chickens.评估重组鸡疟原虫巨噬细胞移动抑制因子作为亚单位疫苗候选物对鸡感染的免疫保护潜力。
Front Immunol. 2025 Jul 11;16:1623743. doi: 10.3389/fimmu.2025.1623743. eCollection 2025.
2
Mapping Inflammatory Markers in Cerebrospinal Fluid Following Aneurysmal Subarachnoid Hemorrhage: An Age- and Sex-Matched Analysis.动脉瘤性蛛网膜下腔出血后脑脊液中炎症标志物的映射:一项年龄和性别匹配分析
Int J Mol Sci. 2025 Feb 3;26(3):1302. doi: 10.3390/ijms26031302.

本文引用的文献

1
Macrophage Migration Inhibitory Factor in Major Depressive Disorder: A Multilevel Pilot Study.在重度抑郁症中巨噬细胞移动抑制因子:多层次的初步研究。
Int J Mol Sci. 2022 Dec 7;23(24):15460. doi: 10.3390/ijms232415460.
2
Emerging Potential of the Phosphodiesterase (PDE) Inhibitor Ibudilast for Neurodegenerative Diseases: An Update on Preclinical and Clinical Evidence.磷酸二酯酶(PDE)抑制剂伊布地尔在神经退行性疾病中的新兴潜力:临床前和临床证据的更新。
Molecules. 2022 Dec 2;27(23):8448. doi: 10.3390/molecules27238448.
3
Neuroprotective Effect of Macrophage Migration Inhibitory Factor (MIF) in a Mouse Model of Ischemic Stroke.
巨噬细胞移动抑制因子(MIF)在缺血性脑卒中小鼠模型中的神经保护作用。
Int J Mol Sci. 2022 Jun 23;23(13):6975. doi: 10.3390/ijms23136975.
4
MIF in the cerebrospinal fluid is decreased during relapsing-remitting while increased in secondary progressive multiple sclerosis.在复发缓解型多发性硬化症中,脑脊液中的 MIF 减少,而在继发性进展型多发性硬化症中则增加。
J Neurol Sci. 2022 Aug 15;439:120320. doi: 10.1016/j.jns.2022.120320. Epub 2022 Jun 13.
5
Thrombin acts as inducer of proinflammatory macrophage migration inhibitory factor in astrocytes following rat spinal cord injury.凝血酶在大鼠脊髓损伤后诱导星形胶质细胞中促炎型巨噬细胞移动抑制因子的表达。
J Neuroinflammation. 2022 May 27;19(1):120. doi: 10.1186/s12974-022-02488-w.
6
Macrophage migration inhibitory factor (MIF) acetylation protects neurons from ischemic injury.巨噬细胞移动抑制因子(MIF)乙酰化保护神经元免受缺血性损伤。
Cell Death Dis. 2022 May 18;13(5):466. doi: 10.1038/s41419-022-04918-2.
7
PAAN/MIF nuclease inhibition prevents neurodegeneration in Parkinson's disease.Paan/MIF 核酸酶抑制可预防帕金森病的神经退行性变。
Cell. 2022 May 26;185(11):1943-1959.e21. doi: 10.1016/j.cell.2022.04.020. Epub 2022 May 10.
8
Iguratimod inhibits skin fibrosis by regulating TGF-β1/Smad signalling pathway in systemic sclerosis.依鲁替尼通过调节系统性硬化症中 TGF-β1/Smad 信号通路抑制皮肤纤维化。
Eur J Clin Invest. 2022 Aug;52(8):e13791. doi: 10.1111/eci.13791. Epub 2022 Apr 27.
9
Soluble TAM receptors sAXL and sTyro3 predict structural and functional protection in Alzheimer's disease.可溶性 TAM 受体 sAXL 和 sTyro3 可预测阿尔茨海默病的结构和功能保护。
Neuron. 2022 Mar 16;110(6):1009-1022.e4. doi: 10.1016/j.neuron.2021.12.016. Epub 2022 Jan 6.
10
Serum Levels of HCY, MIF, and hs-CRP Correlate with Glycolipid Metabolism in Adults with Never-Medicated First-Episode Schizophrenia.未用药的首发精神分裂症成年患者血清同型半胱氨酸、巨噬细胞移动抑制因子和高敏C反应蛋白水平与糖脂代谢相关。
Evid Based Complement Alternat Med. 2021 Nov 13;2021:7394699. doi: 10.1155/2021/7394699. eCollection 2021.